Study highlights need for personalized approaches to prostate cancer screening in high-risk black men |
|
|
|
|
|
The latest prostate cancer news from News Medical |
|
|
|
|
|
 | | A major reason for the unmet need in prostate cancer in the UK is the length of time it takes to get new treatments through the reimbursement system with NICE (National Institute for Health and Care Excellence). This has a long-term impact on the UK, making the UK far behind the rest of Europe and even globally in terms of standard of care. | | | | A novel gene therapy using CRISPR genome editing technology effectively targets cancer-causing "fusion genes" and improves survival in mouse models of aggressive liver and prostate cancers, University of Pittsburgh School of Medicine researchers report in a study published online today in Nature Biotechnology. | |
|
|
|
|